Antonio Curcio, Letizia R Romano, Florinda M Augusto, Giovanni Canino, Elisa Coluccio, Alberto Polimeni, Ciro Indolfi
{"title":"Real-time technical support for guiding remotely ICD/CRT-D implantation.","authors":"Antonio Curcio, Letizia R Romano, Florinda M Augusto, Giovanni Canino, Elisa Coluccio, Alberto Polimeni, Ciro Indolfi","doi":"10.3389/fcvm.2025.1525151","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the electrophysiologic (EP) lab, technical support for implantable cardioverter/defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) procedures is often limited by the availability and costs of field clinical specialist (FCS) bioengineers.</p><p><strong>Methods: </strong>This study explores the viability of using remote support through an internet-based platform for ICD and CRT-D implantation procedures, aiming to enhance efficiency and overcome geographical or pandemic-related barriers. After preclinical phases, thirty patients underwent ICD/CRT-D guided either remotely or with on-site FCS implantation at two primary cardiac care centers, with ten procedures guided remotely and twenty cases with on-site FCS.</p><p><strong>Results: </strong>All procedures in both study arms were successfully completed (100% of cases). Procedural time was shorter in the telemedicine group (<i>P</i> = 0.031). Although fluoroscopic time was slightly reduced in the remote guided group, the difference did not reach statistical significance (<i>P</i> = 0.5). No major adverse events occurred.</p><p><strong>Conclusion: </strong>The study demonstrates the feasibility of remotely supported ICD and CRT-D implantation procedures.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1525151"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925861/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1525151","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In the electrophysiologic (EP) lab, technical support for implantable cardioverter/defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) procedures is often limited by the availability and costs of field clinical specialist (FCS) bioengineers.
Methods: This study explores the viability of using remote support through an internet-based platform for ICD and CRT-D implantation procedures, aiming to enhance efficiency and overcome geographical or pandemic-related barriers. After preclinical phases, thirty patients underwent ICD/CRT-D guided either remotely or with on-site FCS implantation at two primary cardiac care centers, with ten procedures guided remotely and twenty cases with on-site FCS.
Results: All procedures in both study arms were successfully completed (100% of cases). Procedural time was shorter in the telemedicine group (P = 0.031). Although fluoroscopic time was slightly reduced in the remote guided group, the difference did not reach statistical significance (P = 0.5). No major adverse events occurred.
Conclusion: The study demonstrates the feasibility of remotely supported ICD and CRT-D implantation procedures.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.